NOVO-B.CO vs. TRX-USD
NOVO-B.CO (Novo Nordisk A/S) is a stock, while TRX-USD (Tronix) is a cryptocurrency. Over the past 5 years, NOVO-B.CO returned 20.64%/yr vs 35.74%/yr for TRX-USD. At a 0.05 correlation, their price movements are largely independent.
Performance
NOVO-B.CO vs. TRX-USD - Performance Comparison
Loading charts...
Different Trading Currencies
NOVO-B.CO is traded in DKK, while TRX-USD is traded in USD. To make them comparable, the TRX-USD values have been converted to DKK using the latest available exchange rates.
Returns By Period
In the year-to-date period, NOVO-B.CO achieves a -8.64% return, which is significantly lower than TRX-USD's 12.76% return.
NOVO-B.CO
- 1D
- 1.66%
- 1M
- -3.99%
- YTD
- -8.64%
- 6M
- -7.47%
- 1Y
- -41.76%
- 3Y*
- 4.58%
- 5Y*
- 20.64%
- 10Y*
- 17.36%
TRX-USD
- 1D
- 0.00%
- 1M
- -10.07%
- YTD
- 12.76%
- 6M
- 16.98%
- 1Y
- 16.95%
- 3Y*
- 61.03%
- 5Y*
- 35.74%
- 10Y*
- —
NOVO-B.CO vs. TRX-USD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NOVO-B.CO Novo Nordisk A/S | -8.64% | -46.40% | -9.59% | 205.34% | 31.49% | 79.08% | 15.29% | 36.17% | -6.15% | 10.91% |
TRX-USD Tronix | 12.76% | -1.25% | 156.34% | 89.07% | -23.50% | 201.46% | 84.69% | -28.07% | -45.86% | 1,684.29% |
Correlation
The correlation between NOVO-B.CO and TRX-USD is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.06 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.08 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.09 |
Correlation (All Time) Calculated using the full available price history since Sep 12, 2017 | 0.05 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NOVO-B.CO vs. TRX-USD — Risk / Return Rank
NOVO-B.CO
TRX-USD
NOVO-B.CO vs. TRX-USD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NOVO-B.CO) and Tronix (TRX-USD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NOVO-B.CO | TRX-USD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.38 | ||
| Sortino ratioReturn per unit of downside risk | -1.88 | ||
| Omega ratioGain probability vs. loss probability | 0.87 | 1.11 | -0.24 |
| Calmar ratioReturn relative to maximum drawdown | -0.78 | 0.63 | -1.41 |
| Martin ratioReturn relative to average drawdown | -1.15 | 1.14 | -2.30 |
Loading charts...
Drawdowns
NOVO-B.CO vs. TRX-USD - Drawdown Comparison
The maximum NOVO-B.CO drawdown since its inception was -76.75%, smaller than the maximum TRX-USD drawdown of -95.55%. Use the drawdown chart below to compare losses from any high point for NOVO-B.CO and TRX-USD.
Loading charts...
Drawdown Indicators
| NOVO-B.CO | TRX-USD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.75% | -95.55% | +18.80% |
Max Drawdown (1Y)Largest decline over 1 year | -54.63% | -26.90% | -27.73% |
Max Drawdown (3Y)Largest decline over 3 years | -76.75% | -52.64% | -24.11% |
Max Drawdown (5Y)Largest decline over 5 years | -76.75% | -55.66% | -21.09% |
Max Drawdown (10Y)Largest decline over 10 years | -76.75% | — | — |
Current DrawdownCurrent decline from peak | -70.15% | -33.69% | -36.46% |
Average DrawdownAverage peak-to-trough decline | -11.29% | -61.39% | +50.10% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 37.11% | 13.60% | +23.51% |
Volatility
NOVO-B.CO vs. TRX-USD - Volatility Comparison
Novo Nordisk A/S (NOVO-B.CO) has a higher volatility of 11.47% compared to Tronix (TRX-USD) at 8.72%. This indicates that NOVO-B.CO's price experiences larger fluctuations and is considered to be riskier than TRX-USD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NOVO-B.CO | TRX-USD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.47% | 8.72% | +2.75% |
Volatility (6M)Calculated over the trailing 6-month period | 39.57% | 19.22% | +20.35% |
Volatility (1Y)Calculated over the trailing 1-year period | 54.40% | 23.56% | +30.84% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 58.56% | 58.00% | +0.56% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 45.08% | 111.00% | -65.92% |
Frequently Asked Questions
NOVO-B.CO and TRX-USD have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for NOVO-B.CO and TRX-USD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer